AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 67 filers reported holding AMRYT PHARMA PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36,522,011 | +5916.4% | 2,504,939 | +2912.3% | 0.00% | – |
| Q4 2022 | $607,039 | +0.3% | 83,156 | -4.9% | 0.00% | – |
| Q3 2022 | $605,000 | 0.0% | 87,396 | +1.0% | 0.00% | – |
| Q2 2022 | $605,000 | -8.1% | 86,535 | +8.8% | 0.00% | – |
| Q1 2022 | $658,000 | +174.2% | 79,517 | +258.3% | 0.00% | – |
| Q4 2021 | $240,000 | +352.8% | 22,192 | +400.8% | 0.00% | – |
| Q3 2021 | $53,000 | +39.5% | 4,431 | +41.8% | 0.00% | – |
| Q2 2021 | $38,000 | +3700.0% | 3,125 | +4011.8% | 0.00% | – |
| Q1 2021 | $1,000 | – | 76 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
| Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
| Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
| Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
| Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
| Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
| Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |